Quick Overview: Marty Hughes of Cidara Therapeutics explains what he considers the most important factors for selecting and working with ... The pivot from preclinical development to in-human trials is one of the most important transitions in the early life cycle of an ... If you're leading in pharma, biotech, or manufacturing, this is essential listening. This week,
How Can Cdmo S Succeed - Detailed Overview & Context
Marty Hughes of Cidara Therapeutics explains what he considers the most important factors for selecting and working with ... The pivot from preclinical development to in-human trials is one of the most important transitions in the early life cycle of an ... If you're leading in pharma, biotech, or manufacturing, this is essential listening. This week, 95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't ... At our recent Outsourced Pharma Live, “ Companies developing new biologics have high expectations and the smallest details
Welcome to episode 061 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar sits down with Kevin ... Why are US pharmaceutical companies increasingly partnering with Canadian Presented By: Javier García Cogorro Speaker Biography: Javier García is an entrepreneur and investor with more than 35 years ... At our second OP-Virtual, Outsourced Pharma Chief Editor Louis Garguilo invited professionals who have had careers at both ... Contract development and manufacturing organizations (a.k.a. In biologics outsourcing, finding the right
The pharmaceutical industry is a constantly changing and highly regulated world, hence understanding what Kurt Neilsen, who has been both a pharma executive and CEO of a
